A Study is to Evaluate a Regimen on Gingivitis Using Traditional and Novel Assessment Methods

Inclusion criteria

• Provide written informed consent to participate in the study;
• Be 18 years of age or older;
• Agree not to participate in any other oral/dental product studies during the course of this study;
• Agree to delay any elective dentistry (including dental prophylaxis) until the study has been completed;
• Agree to refrain from any form of non-specified oral hygiene during the treatment periods, including but not limited to the use of products such as floss or whitening products;
• Have a Baseline MGI score of at least 1.75 but not greater than 2.3;
• Have at least 20 bleeding sites (sites with a score of 1 or 2 on the GBI index);
• Agree to return for all scheduled visits and follow study procedures;
• Be in good general health, as determined by the Investigator/designee based on a review of the health history/update for participation in the study.

Exclusion criteria

• Have had a dental prophylaxis within 2 weeks of Baseline visit;
• Have taken antibiotics or used anti-gingivitis / anti-bacterial oral care products such as chlorhexidine or Listerine within 2 weeks of plaque sampling visits;
• Have rampant caries, open or untreated caries, severe gingivitis, or advanced periodontitis requiring prompt treatment; or,
• Need an antibiotic prophylaxis prior to dental visits,
• Present with any disease or condition(s) that could be expected to interfere with examination procedures or the subject's safe completion of the study,
• Are pregnant (Self-reported) or lactating.